<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "crizotinib cap">
<dose><value>200</value>
<value>250</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>200 mg</value>
<value>250 mg</value>
</strength>
<frequency><value>BID</value>
<value>DAILY</value>
</frequency>
<instruction></instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population><value>Crizotinib. Metastatic Non-Small Cell Lung Cancer</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Continuous dosing; 1 cycle = 30 days to correspond with ARIA orders.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6121</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6122</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert><value>HIGH ALERT MEDICATION</value>
</HighAlert>
</drug>